Technavio analysts forecast the global immunodiagnostics market to grow at a steady CAGR of almost 8% during the forecast period, according to their latest report.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170119005468/en/

Technavio has published a new report on the global immunodiagnostics market from 2017-2021. (Photo: Business Wire)

The research study covers the present scenario and growth prospects of the global immunodiagnostics market for 2017-2021. To calculate the market size, Technavio analysts consider the revenue generated from the sales of immunodiagnostics devices.

Market overview:

  • Global immunodiagnostics market is well established in developed countries like the US, the UK, Germany, and France due to the high level of automation in laboratories for high accuracy and efficiency.
  • There are huge growth opportunities in emerging countries like Brazil, China, and India.
  • The oncology and endocrinology segment has been the largest revenue contributor to the market in 2016. A rise in R&D in oncology has increased the demand for biomarker-based immunodiagnostic tests.

Request a sample report: http://www.technavio.com/request-a-sample?report=55888

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Technavio healthcare and life sciences analysts highlight the following three factors that are contributing to the growth of the global immunodiagnostics market:

Technological advances

The incidence of autoimmune diseases is rising worldwide, thus increasing the volume of samples collected for analysis. This has led to a greater demand for automation for rapid analysis and interpretation of results from autoimmune disease diagnostics. Automation involves a series of integrated steps that include pre-analytical and post-analytical stages, which help lower the need for manual intervention, thus avoiding errors.

Srinivas Sashidhar, a lead in-vitro diagnostics research analyst at Technavio, says, “Decentralized testing for autoimmune disease diagnosis is gaining popularity. This procedure reduces the time spent in sending the sample for analysis from central laboratories.”

Increasing adoption of POCT

In 2012, an emerging company, Trillium Diagnostics, licensed a cell-free DNA sepsis marker to develop new immunodiagnostics. Traditional companies offering sepsis POCT devices in Europe and the US include Axis Shield, Roche Diagnostics, and bioMérieux.

“POCT for cardiovascular biomarkers is a strategic immunodiagnostic focus area, even for non-traditional healthcare companies. In 2011, Samsung Electronics acquired Nexus Dx, a developer of rapid POCT for diagnosing cardiovascular diseases,” adds Srinivas.

Product development

The rise in blood donations worldwide and stringent regulations for approval of hematology products have led to the development of automated hematology analyzers. With the increase in blood donations, there are high chances of blood-related infections and transfer of diseases.

Danaher’s automated hematology analyzers increase the accuracy of detection of diseases in blood samples. Cell counting with automated analyzers is rapid, objective, and significant (8,000 or more cells can be counted), and is not subject to distributional bias as in manual counting.

Top vendors:

  • Abbott Laboratories
  • Danaher
  • Roche Diagnostics
  • Siemens Healthineers

Browse Related Reports:

  • Global Hepatitis B and C Diagnostics Market 2016-2020
  • Global Medical Imaging Left Atrial Appendage Closure Market 2017-2021
  • Clinical Immunoassay Analyzer Market in the US 2016-2020

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like oncology, and vaccines, and medical imaging. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 630 333 9501UK: +44 208 123 1770www.technavio.com